OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

Disperazol Pharma, a leading biotechnology firm that develops compounds that dismantle biofilms of critical Gram—negative pathogens, today announced that it has joined the AMR Industry Alliance.

Mohit Bansal, an analyst from Wells Fargo, assigned the Buy rating on Ironwood Pharma (IRWD – Research Report). The associated price target is $7.00. Mohit Bansal has given his Buy rating due to ...

Could the drug ads that flash across your television screen offering better health soon be coming to an end? President Donald Trump’s nominee for health and human services secretary, Robert F ...

The joint company will be 55% owned by Vifor Pharma and 45% by Fresenius Kabi. Fresenius Kabi will be fully responsible for the marketing of Vifor’s intravenous iron portfolio in China.

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

The European Commission (EC) is seeking comments on the proposal, which comes two years after it launched an investigation into potentially misleading messaging issued by Vifor Pharma about ...

Amid Biden admin's drug-pricing push, Big Pharma kicks off 2024 with hundreds of price hikes: report There also were a few significant price decreases of note for products that are in decline ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

HERZLIYA, Israel and CALGARY, AB, Jan. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a ...

Sanofi S.A. Part Cert-1.97% €8.03M ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...